Banque Cantonale Vaudoise’s AstraZeneca AZN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Buy	+60,462	New	+$11.4M	1.57%	10
2026 Q1	–	Sell	-383	Closed	-$70K	–	874
2025 Q4	$70K	Buy	383 +7	+2%	+$1.23K	﹤0.01%	665
2025 Q3	$58K	Sell	376 -46	-11%	-$6.96K	﹤0.01%	669
2025 Q2	$59K	Hold	422	–	–	﹤0.01%	633
2025 Q1	$62K	Buy	+422	New	+$61.1K	﹤0.01%	667
2024 Q3	$69K	Sell	442 -693	-61%	-$112K	﹤0.01%	593
2024 Q2	$177K	Buy	1,135 +500	+79%	+$75.2K	0.01%	616
2024 Q1	$86K	Hold	635	–	–	﹤0.01%	694
2023 Q4	$86K	Sell	635 -139	-18%	-$18.1K	﹤0.01%	712
2023 Q3	$105K	Hold	774	–	–	0.01%	820
2023 Q2	$111K	Hold	774	–	–	0.01%	839
2023 Q1	$107K	Hold	774	–	–	0.01%	845
2022 Q4	$105K	Hold	774	–	–	0.01%	848
2022 Q3	$85K	Hold	774	–	–	﹤0.01%	906
2022 Q2	$102K	Hold	774	–	–	0.01%	889
2022 Q1	$102K	Hold	774	–	–	﹤0.01%	921
2021 Q4	$90K	Hold	774	–	–	﹤0.01%	975
2021 Q3	$93K	Buy	774 +139	+22%	+$16.2K	﹤0.01%	950
2021 Q2	$76K	Sell	635 -1,943	-75%	-$213K	﹤0.01%	1001
2021 Q1	$256K	Buy	2,578 +1,943	+306%	+$195K	0.01%	717
2020 Q4	$63K	Hold	635	–	–	﹤0.01%	913
2020 Q3	$70K	Buy	+635	New	+$70.6K	﹤0.01%	877

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Banque Cantonale Vaudoise's AZN Position: Q2 2026 in Review

Banque Cantonale Vaudoise opened a new position in AstraZeneca (AZN) in Q2 2026: 60,462 shares worth $11.3M. The stake represents 1.57% of the portfolio and ranks #10 among its holdings. This is a return to the name: Banque Cantonale Vaudoise previously reported a position in AZN as recently as Q4 2025.

Banque Cantonale Vaudoise first reported a position in AZN in Q3 2020 and has held it in 22 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Banque Cantonale Vaudoise held 60,462 shares of AstraZeneca worth $11.3M as of Q2 2026.
AstraZeneca was a new Banque Cantonale Vaudoise position in Q2 2026.
AstraZeneca made up 1.57% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #10 holding.
Banque Cantonale Vaudoise first reported a position in AstraZeneca in Q3 2020 and has held it in 22 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.